British Journal of Cancer Q1 Unclaimed
British Journal of Cancer is a journal indexed in SJR in Oncology and Cancer Research with an H index of 236. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 2700 €. The scope of the journal is focused on Clinical Cancer, Oncology, Radiotherapy, Chemotherapy. It has an SJR impact factor of 2,833 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,833.
British Journal of Cancer focuses its scope in these topics and keywords: cancer, breast, cell, study, lung, patients, expression, tumour, chemotherapy, human, ...
Type: Journal
Type of Copyright: CC BY
Languages: English
Open Access Policy: Open Choice
Type of publications:
Publication frecuency: -
2700 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
2,833
SJR Impact factor236
H Index457
Total Docs (Last Year)1155
Total Docs (3 years)19555
Total Refs7208
Total Cites (3 years)1049
Citable Docs (3 years)5,94
Cites/Doc (2 years)42,79
Ref/DocOther journals with similar parameters
JAMA oncology Q1
Annals of Oncology Q1
Molecular Cancer Q1
CA - A Cancer Journal for Clinicians Q1
Cancer Discovery Q1
Compare this journals
Aims and Scope
Best articles by citations
Lack of involvement of known oncogenic DNA viruses in Epstein-Barr virus-negative Hodgkin's disease
View moreThe taxanes: toxicity and quality of life considerations in advanced ovarian cancer
View moreGonadal function in male patients after treatment for malignant lymphomas, with emphasis on chemotherapy
View moreInterventions to promote cancer awareness and early presentation: systematic review
View moreSecond primary breast cancer after Hodgkin's disease
View moreDeleterious effect of serum proteins on the amphotericin B-induced potentiation of cisplatin in human colon cancer cells
View moreExtensive experience of disease control with gefitinib and the role of prognostic markers
View moreDocetaxel: an alternative taxane in ovarian cancer
View moreTrends and projections in adenocarcinoma and squamous cell carcinoma of the oesophagus in England from 1971 to 2037
View moreEpstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma
View moreUrinary tract infections and reduced risk of bladder cancer in Los Angeles
View moreSexual quality of life in Hodgkin Lymphoma: a longitudinal analysis by the German Hodgkin Study Group
View moreThe National Awareness and Early Diagnosis Initiative in England: assembling the evidence
View moreFaecal bile acids and clostridia in the aetiology of colorectal cancer
View moreGonorrhoea and male bladder cancer in a prospective study
View moreNuclear expression of Survivin in paediatric ependymomas and choroid plexus tumours correlates with morphologic tumour grade
View moreRT Prepare: a radiation therapist-delivered intervention reduces psychological distress in women with breast cancer referred for radiotherapy
View moreProtracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I/II dose escalation study
View moreFamily history of breast cancer and young age at diagnosis of breast cancer increase risk of second primary malignancies in women: a population-based cohort study
View moreRelationship between paediatric CT scans and subsequent risk of leukaemia and brain tumours: assessment of the impact of underlying conditions
View moreA comparative study between catalase gene therapy and the cardioprotector monohydroxyethylrutoside (MonoHER) in protecting against doxorubicin-induced cardiotoxicity in vitro
View moreA visual summary of the EUROCARE-4 results: a UK perspective
View moreFamily history of cancer as a risk factor for second malignancies after Hodgkin's lymphoma
View moreAccelerated regrowth of non-small-cell lung tumours after induction chemotherapy
View more
If you are a journal editor you can claim the journal profile and add new information for the visitors.
Comments